On April 10th, NCHC President & CEO John Rother presented at the World Orphan Drug Congress 2019 Conference & Expo to discuss potential policy options to address the rising cost of drugs. Mr. Rother discussed proposals from the FDA, HHS, and Congress. Mr. Rother also identified 4 feasible options to address drug affordability. The slides […]
As part of its mission to bring together stakeholders to achieve an affordable, high-value health system, NCHC advocates for constructive policy change. While some members of NCHC do not, or cannot, take positions either on specific legislation, strategies, or on any policies outside their respective mission areas, all that can, do endorse broad policy positions in support of comprehensive health system change. Here is the policy correspondence sent from the National Coalition on Health Care.
Here, you will find all of NCHC's policy correspondence from 2017-present. Please see here for all 2016 and previous policy correspondence.
Juvenile diabetes is an autoimmune disorder that affects over 1.25 million Americans. Also known as Type 1 diabetes, it occurs when the body stops producing the blood-glucose regulating hormone insulin; thus, juvenile diabetics must receive consistent insulin therapy to survive. Although insulin was discovered in the 1920s, prices for the drug are astronomical by today’s […]
On February 28th, NCHC wrote a letter to the Senate HELP Committee addressed to Senator Alexander. The letter was in response to a request from Senator Alexander asking for policy recommendations to address the rising costs of health care. You can read the entire letter here.
On December 31st, 2018, the National Coalition on Health Care commented on CMS’ requirements for Medicare Advantage plans that offer additional telehealth benefits. NCHC noted that the “current limitations on the use of telehealth services are antiquated,” pointing to the fact that it was estimated that only 0.25 percent of Medicare beneficiaries were able to […]
On December 21, 2018, NCHC wrote a letter to legislators that supported S. 3592, the No More Surprise Bills Act of 2018. The effects of surprise medical bills effect thousands of people on a daily basis and the problems associated with these bills are growing, creating negative financial consequences for patients and the entire health […]